ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 198 filers reported holding ACORDA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 7.74 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,000 | +50.0% | 7,904 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -20.0% | 7,904 | -4.8% | 0.00% | – |
| Q2 2020 | $5,000 | -85.3% | 8,304 | -76.7% | 0.00% | – |
| Q1 2020 | $34,000 | -67.6% | 35,605 | -30.8% | 0.00% | – |
| Q4 2019 | $105,000 | -0.9% | 51,457 | +38.2% | 0.00% | – |
| Q3 2019 | $106,000 | -92.3% | 37,247 | -79.1% | 0.00% | -100.0% |
| Q2 2019 | $1,368,000 | +191.7% | 178,431 | +405.8% | 0.00% | – |
| Q1 2019 | $469,000 | -85.2% | 35,280 | -82.7% | 0.00% | -100.0% |
| Q4 2018 | $3,173,000 | +398.1% | 203,653 | +528.2% | 0.00% | – |
| Q3 2018 | $637,000 | +20.2% | 32,416 | +75.5% | 0.00% | – |
| Q2 2018 | $530,000 | +142.0% | 18,473 | +99.6% | 0.00% | – |
| Q1 2018 | $219,000 | -67.8% | 9,257 | -70.8% | 0.00% | – |
| Q4 2017 | $681,000 | -62.8% | 31,741 | -58.9% | 0.00% | -100.0% |
| Q3 2017 | $1,829,000 | -25.4% | 77,314 | -37.8% | 0.00% | -50.0% |
| Q2 2017 | $2,451,000 | +51.8% | 124,362 | +61.8% | 0.00% | +100.0% |
| Q1 2017 | $1,615,000 | -52.8% | 76,869 | -57.8% | 0.00% | -66.7% |
| Q4 2016 | $3,424,000 | +268.6% | 182,199 | +309.9% | 0.00% | +200.0% |
| Q3 2016 | $929,000 | +68.9% | 44,451 | +106.3% | 0.00% | – |
| Q2 2016 | $550,000 | -42.7% | 21,546 | -40.6% | 0.00% | -100.0% |
| Q1 2016 | $960,000 | +315.6% | 36,282 | +574.8% | 0.00% | – |
| Q4 2015 | $231,000 | -53.0% | 5,377 | -71.0% | 0.00% | – |
| Q3 2015 | $492,000 | +187.7% | 18,521 | +260.2% | 0.00% | – |
| Q2 2015 | $171,000 | -5.0% | 5,142 | -5.1% | 0.00% | – |
| Q1 2015 | $180,000 | -61.7% | 5,418 | -52.9% | 0.00% | – |
| Q4 2014 | $470,000 | +32.8% | 11,500 | +10.1% | 0.00% | – |
| Q3 2014 | $354,000 | -27.6% | 10,443 | -28.1% | 0.00% | – |
| Q2 2014 | $489,000 | -40.1% | 14,520 | -32.6% | 0.00% | -100.0% |
| Q1 2014 | $817,000 | +82.8% | 21,556 | +40.9% | 0.00% | – |
| Q4 2013 | $447,000 | +61.4% | 15,301 | +89.6% | 0.00% | – |
| Q3 2013 | $277,000 | +290.1% | 8,072 | +270.6% | 0.00% | – |
| Q2 2013 | $71,000 | – | 2,178 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |